Bharat Biotech previously said that it will offer the intranasal vaccine for Rs 325 per shot for government procurement.
Bharat Biotech, a homegrown vaccine manufacturer, said on Saturday that their intranasal COVID-19 vaccine iNCOVACC, the first of its type in India, will be available on January 26.
Ella told children at the India International Science Festival in Bhopal that the domestic vaccine for lumpy skin disease in cattle, Lumpi-ProVacInd, is expected to be released next month.
“Our nasal vaccine will be officially launched on January 26, on Republic Day,” Ella said, participating in the ‘Face-to-Face with New Frontiers in Science’ segment of the IISF, organised at the Maulana Azad National Institute of Technology (MANIT).
In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 per shot for private vaccination centres.